17,261 trials
Cholangiocarcinoma
Primary: Objective Response Rate (ORR) in Participants With FGFR2 Rearrangements or Fusions — 37.0 percentage of participants
BRCA1 Mutation Carrier · BRCA2 Mutation Carrier · Ductal Breast Carcinoma In Situ
Primary: Mean Levels of Telapristone Acetate in Breast Tissue — 2.82; 103 ng/g
Dry Eye
Primary: Photographic Assessment of Bulbar Conjunctival Hyperemia Change in Score From Baseline (CFB) at 15 Days (Evaluated Via Central Reading Center). — -0.51; -0.43; -0.21…
Endometrial Cancer · Recurrent Endometrial Cancer
Primary: Clinical Benefit Rate (CBR) — 7; 18 Participants
Acute Hypoxemic Respiratory Failure
Primary: Time to Non-invasive/Invasive Mechanical Ventilation — 96.65; 70.49 Hours — p=0.782
Bacterial Vaginosis
Primary: Proportion of Participants With Recurrent Bacterial Vaginosis (RBV) by Visit 4, as Defined by Presence of at Least 3 Amsel Criteria — 0.581; 0.697 proportion of…
Advanced Breast Cancer · HER2/Neu Negative · Triple-Negative Breast Cancer
Primary: Objective Response (OR) — 0; 0; 0; 3 Participants
Chronic Hepatitis D Infection
Primary: ≥2 log10 Decline of HDV RNA From Baseline at End of Treatment (EOT) — 1; 0; 1; 0 Participants
Hematologic Malignancy
Primary: Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs) — 17 Participants
Cervical Adenocarcinoma · Cervical Adenosquamous Carcinoma · Cervical Squamous Cell Carcinoma, Not Otherwise Specified
Primary: Number of Participants With Objective Response Rate (ORR, Either Partial or Complete Response) Defined by Response Evaluation Criteria in Solid Tumors (RECIST) Version…
Acute Biphenotypic Leukemia · Acute Lymphoblastic Leukemia in Remission · Acute Myeloid Leukemia in Remission
Primary: Number of Participants With Graft Failure/Rejection — 2; 5 Participants
Tuberculosis
Primary: Daily Change in log10 Colony-forming Unit (CFU) — -0.06; -0.18; -0.21; -0.15 log10 CFU per mL sputum per day
Porphyria Cutanea Tarda
Primary: Remission — 6.1; 6.9 months
Radiation Injury
Primary: Change in Pulmonary Function, as Measured by Ventilation Defect Percentage (VDP) — -2.20 Ventilation Defect Percentage (VDP) — p=0.22
Esophageal Carcinoma
Primary: Delayed Gastric Emptying Assessed Radiographically by Nuclear Medicine Emptying Study — 12; 14; 1; 3 Participants — p=0.773